Elevated prostate androgens in African American men mediated by megalin import of testosterone and 25-hydroxyvitamin D status

Vitamin D deficiency associates with an increased risk of prostate cancer (PCa) mortality and is hypothesized to contribute to PCa aggressiveness and disparities in African Americans. There is a relationship between African-ancestry, circulating and intraprostatic vitamin D metabolites and prostatic expression of megalin, an endocytic receptor that internalizes globulin-bound hormones. Here, we demonstrate that megalin imports sex hormone-binding globulin-bound testosterone in prostate cells and prostatic loss of Lrp2 (megalin) results in reduced prostate androgen levels. Megalin expression is suppressed by 25-hydroxyvitamin D (25D) in cell lines, patient-derived prostate epithelial cells, and prostate tissue explants, indicating a negative feedback loop. The relationships between hormones in patients support this feedback as prostatic DHT levels are higher in African American men and inversely correlate with serum 25D status. Megalin levels are reduced in localized PCa by Gleason Grade and in patients with future disease recurrence. Our findings highlight the impact of vitamin D deficiency on prostate androgen levels, which are known drivers of PCa, and reveal a potential mechanistic link between vitamin D and the PCa disparities observed in African Americans.

[1]  Patrick R. Alba,et al.  Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System , 2022, JAMA network open.

[2]  D. Pe’er,et al.  Regenerative potential of prostate luminal cells revealed by single-cell analysis , 2020, Science.

[3]  I. Thompson,et al.  Long-Term Effects of Finasteride on Prostate Cancer Mortality. , 2019, The New England journal of medicine.

[4]  Takafumi N. Yamaguchi,et al.  Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories. , 2018, Cancer cell.

[5]  R. Mason,et al.  1,25-Dihydroxycholecalciferol (calcitriol) modifies uptake and release of 25-hydroxycholecalciferol in skeletal muscle cells in culture , 2017, The Journal of Steroid Biochemistry and Molecular Biology.

[6]  P. Carroll,et al.  Relationships between Circulating and Intraprostatic Sex Steroid Hormone Concentrations , 2017, Cancer Epidemiology, Biomarkers & Prevention.

[7]  R. Kittles,et al.  Prostatic compensation of the vitamin D axis in African American men. , 2017, JCI insight.

[8]  D. Richard,et al.  Sex Hormone Binding Globulin Modifies Testosterone Action and Metabolism in Prostate Cancer Cells , 2016, International journal of endocrinology.

[9]  R. Kittles,et al.  Associations Between Serum Vitamin D and Adverse Pathology in Men Undergoing Radical Prostatectomy. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  P. Kraft,et al.  Circulating vitamin D, vitamin D–related genetic variation, and risk of fatal prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium , 2015, Cancer.

[11]  L. Arab,et al.  Association between Plasma 25-Hydroxyvitamin D, Ancestry and Aggressive Prostate Cancer among African Americans and European Americans in PCaP , 2015, PloS one.

[12]  E. Platz,et al.  Racial variation in sex steroid hormone concentration in black and white men: a meta‐analysis , 2014, Andrology.

[13]  R. Kittles,et al.  Vitamin D Deficiency Predicts Prostate Biopsy Outcomes , 2014, Clinical Cancer Research.

[14]  E. Giovannucci,et al.  The role of vitamin D in reducing cancer risk and progression , 2014, Nature Reviews Cancer.

[15]  R. Nolley,et al.  Optimization and comprehensive characterization of a faithful tissue culture model of the benign and malignant human prostate , 2013, Laboratory Investigation.

[16]  B. Boyan,et al.  Plasma membrane Pdia3 and VDR interact to elicit rapid responses to 1α,25(OH)(2)D(3). , 2013, Cellular signalling.

[17]  S. Sengul,et al.  Receptor-Associated Protein Blocks Internalization and Cytotoxicity of Myeloma Light Chain in Cultured Human Proximal Tubular Cells , 2013, PloS one.

[18]  T. H. van der Kwast,et al.  Tumor Suppressor microRNAs, miR-100 and -125b, Are Regulated by 1,25-dihydroxyvitamin D in Primary Prostate Cells and in Patient Tissue , 2013, Cancer Prevention Research.

[19]  G. Andriole,et al.  The REDUCE Follow-Up Study: low rate of new prostate cancer diagnoses observed during a 2-year, observational, followup study of men who participated in the REDUCE trial. , 2013, The Journal of urology.

[20]  Michael N. Ferrandino,et al.  Race is associated with discontinuation of active surveillance of low-risk prostate cancer: Results from the Duke Prostate Center , 2012, Prostate Cancer and Prostatic Diseases.

[21]  E. Christensen,et al.  Endocytic receptors in the renal proximal tubule. , 2012, Physiology.

[22]  R. Kittles,et al.  Predictors of Serum Vitamin D Levels in African American and European American Men in Chicago , 2012, American journal of men's health.

[23]  S. Kahn,et al.  Interactions of sex hormone-binding globulin with target cells , 2010, Molecular and Cellular Endocrinology.

[24]  E. Casanova,et al.  A Probasin‐MerCreMer BAC allows inducible recombination in the mouse prostate , 2009, Genesis.

[25]  I. Thompson,et al.  Finasteride Does Not Increase the Risk of High-Grade Prostate Cancer: A Bias-Adjusted Modeling Approach , 2008, Cancer Prevention Research.

[26]  P. Nelson,et al.  Association of Megalin Genetic Polymorphisms with Prostate Cancer Risk and Prognosis , 2008, Clinical Cancer Research.

[27]  R. DiPaola,et al.  Vitamin D Inhibits the Formation of Prostatic Intraepithelial Neoplasia in Nkx3.1; Pten Mutant Mice , 2006, Clinical Cancer Research.

[28]  D. Peehl,et al.  Inhibition of p38 by vitamin D reduces interleukin-6 production in normal prostate cells via mitogen-activated protein kinase phosphatase 5: implications for prostate cancer prevention by vitamin D. , 2006, Cancer research.

[29]  H. Schulz,et al.  Role of Endocytosis in Cellular Uptake of Sex Steroids , 2005, Cell.

[30]  T. Higashi,et al.  Determination of prostatic androgens in 10 mg of tissue using liquid chromatography–tandem mass spectrometry with charged derivatization , 2005, Analytical and bioanalytical chemistry.

[31]  M. Schell,et al.  Racial differences in prostate androgen levels in men with clinically localized prostate cancer. , 2004, The Journal of urology.

[32]  C. Wagner,et al.  Kidney-specific inactivation of the megalin gene impairs trafficking of renal inorganic sodium phosphate cotransporter (NaPi-IIa). , 2004, Journal of the American Society of Nephrology.

[33]  S. Moestrup,et al.  Cubilin- and megalin-mediated uptake of albumin in cultured proximal tubule cells of opossum kidney. , 2000, Kidney international.

[34]  H. Vorum,et al.  Megalin knockout mice as an animal model of low molecular weight proteinuria. , 1999, The American journal of pathology.

[35]  Henrik Vorum,et al.  An Endocytic Pathway Essential for Renal Uptake and Activation of the Steroid 25-(OH) Vitamin D3 , 1999, Cell.

[36]  D K Burns,et al.  Defective forebrain development in mice lacking gp330/megalin. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[37]  C. Mendel The free hormone hypothesis: a physiologically based mathematical model. , 1989, Endocrine reviews.

[38]  P. Dhawan,et al.  Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. , 2016, Physiological reviews.

[39]  K. Forrest,et al.  Prevalence and correlates of vitamin D deficiency in US adults. , 2011, Nutrition research.

[40]  R. Boland,et al.  1,25(OH)2‐vitamin D3 induces translocation of the vitamin D receptor (VDR) to the plasma membrane in skeletal muscle cells , 2002, Journal of cellular biochemistry.